These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1175271)

  • 1. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.
    Pine M; Favrot L; Smith S; McDonald K; Chidsey CA
    Circulation; 1975 Nov; 52(5):886-93. PubMed ID: 1175271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
    Thadani U; Parker JO
    Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relation between myocardial oxygen consumption and ischemia during exertion in patients with angina pectoris: effect of propranolol].
    Galvani M; Bugiardini R; Ferrini D; Gridelli C; Mari L; Pozzati A; Ferramosca B; Puddu P
    G Ital Cardiol; 1985 Nov; 15(11):1032-8. PubMed ID: 3007250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic actions of nitrite-beta-adrenergic blocking agents in the therapy of angina pectoris. Pharmacologic and therapeutic rationale.
    Klein HO; Berger HJ
    Cardiology; 1973; 58(6):313-25. PubMed ID: 4153989
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake.
    Kodama Y; Yokota M; Miyahara T; Matsunami T; Sobue T; Saito H
    Am Heart J; 1993 Sep; 126(3 Pt 1):587-93. PubMed ID: 8362713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
    Borer JS; Comerford MB; Sowton E
    J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of angina pectoris. Therapeutic methods and physiologic mechanisms.
    Amsterdam EA; Hughes JL; Miller RR; Massumi RA; Zelis R; Mason DT
    Adv Cardiol; 1974; 11(00):175-90. PubMed ID: 4213235
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 12. Variable response to atrial pacing after intravenous propranolol in patients with stable exertional angina.
    De Servi S; Ferrario M; Ghio S; Cioffi P; Angoli L; Bramucci E; Aimè E; Montericcio V; Specchia G
    Eur Heart J; 1990 Nov; 11(11):997-1005. PubMed ID: 2282930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical therapy of angina pectoris.
    Parmley WW
    Angiology; 1977 Dec; 28(12):865-72. PubMed ID: 414639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response effectiveness of propranolol for the treatment of angina pectoris.
    Alderman EL; Davies RO; Crowley JJ; Lopes MG; Brooker JZ; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Circulation; 1975 Jun; 51(6):964-75. PubMed ID: 805675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease.
    Lewis CM; Brink AJ
    Am J Cardiol; 1968 Jun; 21(6):846-59. PubMed ID: 5678218
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma propranolol concentration in patients with angina and acute myocardial infarction.
    Rutherford JD; Singh BN; Ambler PK; Norris RM
    Clin Exp Pharmacol Physiol; 1976; 3(4):297-304. PubMed ID: 975619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol and angina pectoris.
    Wolfson S; Heinle RA; Herman MV; Kemp HG; Sullivan JM; Gorlin R
    Am J Cardiol; 1966 Sep; 18(3):345-53. PubMed ID: 5922884
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol in angina pectoris: comparison of therapy given two and four times daily.
    Thadani U; Parker JO
    Am J Cardiol; 1980 Jul; 46(1):117-23. PubMed ID: 7386384
    [No Abstract]   [Full Text] [Related]  

  • 20. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
    Olowoyeye JO; Thadani U; Parker JO
    Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.